AI Summary
- Reduced plasma C-mannosyl tryptophan levels observed in patients with major depressive disorder compared with controls.
- Findings suggest C-mannosyl tryptophan as a candidate biomarker for diagnosis or treatment monitoring in MDD.
- Results indicate altered tryptophan-related metabolism in MDD and warrant larger studies to confirm clinical utility and mechanisms.
Psychiatry Clin Neurosci. 2026 Aug 20. doi: 10.1111/pcn.70119. Online ahead of print.
NO ABSTRACT
PMID:42622332 | DOI:10.1111/pcn.70119
Share Evidence Blueprint
Save to Google Notes
Search Google Scholar
Save as PDF
⭐ My Revision List
